These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19890371)

  • 1. Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension.
    Kjeldsen SE; Stålhammar J; Hasvold P; Bodegard J; Olsson U; Russell D
    J Hum Hypertens; 2010 Apr; 24(4):263-73. PubMed ID: 19890371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
    Suzuki H; Kanno Y;
    Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartan.
    Russell D; Stålhammar J; Bodegard J; Hasvold P; Thuresson M; Kjeldsen SE
    J Clin Hypertens (Greenwich); 2011 Mar; 13(3):189-97. PubMed ID: 21366850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency.
    Nakamura T; Kanno Y; Takenaka T; Suzuki H;
    Hypertens Res; 2005 May; 28(5):415-23. PubMed ID: 16156505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of treatment with losartan vs candesartan and mortality among patients with heart failure.
    Svanström H; Pasternak B; Hviid A
    JAMA; 2012 Apr; 307(14):1506-12. PubMed ID: 22496265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
    Kasanuki H; Hagiwara N; Hosoda S; Sumiyoshi T; Honda T; Haze K; Nagashima M; Yamaguchi J; Origasa H; Urashima M; Ogawa H;
    Eur Heart J; 2009 May; 30(10):1203-12. PubMed ID: 19346521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis.
    Grosso AM; Bodalia PN; Macallister RJ; Hingorani AD; Moon JC; Scott MA
    Int J Clin Pract; 2011 Mar; 65(3):253-63. PubMed ID: 21284790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.
    Hasvold LP; Bodegård J; Thuresson M; Stålhammar J; Hammar N; Sundström J; Russell D; Kjeldsen SE
    J Hum Hypertens; 2014 Nov; 28(11):663-9. PubMed ID: 25211055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.
    Asmar R; Lacourcière Y
    J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effects of combination therapy with losartan and low-dose hydrochlorothiazide in the treatment of essential hypertension].
    Minami J; Ishimitsu T; Matsuoka H
    Nihon Jinzo Gakkai Shi; 2005; 47(8):864-9. PubMed ID: 16408430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
    Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
    Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan vs candesartan for heart failure.
    Lund LH; Benson L
    JAMA; 2012 Jul; 308(4):336; author reply 336-7. PubMed ID: 22820775
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
    Fridman KU; Elmfeldt D; Wysocki M; Friberg PR; Andersson OK
    Blood Press; 2002; 11(4):244-52. PubMed ID: 12361194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-care costs of losartan and candesartan in the primary treatment of hypertension.
    Henriksson M; Russell D; Bodegard J; Kjeldsen S; Hasvold P; Stålhammar J; Levin LÅ
    J Hum Hypertens; 2011 Feb; 25(2):130-6. PubMed ID: 20376078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
    Ohma KP; Milon H; Valnes K
    Blood Press; 2000; 9(4):214-20. PubMed ID: 11055474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of candesartan vs losartan with all-cause mortality in patients with heart failure.
    Eklind-Cervenka M; Benson L; Dahlström U; Edner M; Rosenqvist M; Lund LH
    JAMA; 2011 Jan; 305(2):175-82. PubMed ID: 21224459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
    Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A;
    J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.